Abstract:Natural killer/T cell lymphoma (NKTCL) is an aggressive subtype of non-Hodgkin lymphoma that is rare overall but has a higher prevalence in Chinese and Hispanic populations. Recent sequencing efforts have improved the understanding of the disease and revealed a number of genes that may drive the pathogenesis of NKTCL. These efforts were largely limited by the number of cases studied. Based on previously reported whole exome sequencing data in NKTCL and other lymphoid malignancies and on the frequency and potential biological significance of the mutant, we designed a 334-gene panel and sequenced 105 NKTCLs. We characterized single nucleotide variants (SNVs), small insertions and deletions (indels), and copy number alterations (CNAs) that may have pathogenic roles. Tumor DNA was isolated from 74 Chinese and 31 Hispanic NKTCL patients. For 7 of these, matched normal DNA was extracted from peripheral blood. The 334 genes in the custom panel were captured using the Agilent SureSelect platform, and the exons of these genes were sequenced on an Illumina HiSeq 2500 instrument. For cases without matched normal samples, we discriminated between somatic and germline variants with an in-house machine learning algorithm which is based on information of public variant databases, variant annotations, and sequencing statistics, and followed by manual inspection. CNAs were determined based on the untargeted sequences using an R package, CopywriteR . We identified a total of 479 SNVs and 113 indels in 155 genes in 102 out of 105 patients. Mutations in STAT3 and JAK3 were identified in 30% and 7% of the cases, respectively. The hotspot mutations Y640F, S614R, and G618R in the SH2 domain of STAT3 and A573V of the JH2 domain of JAK3 were observed in most of these cases. 46% of the cases harbored one or more mutations in epigenetic regulators ARID1A , EP300 , MLL2 , MLL3 , and TET2 . Transcription co-repressors BCOR and NCOR2 were mutated in 25 of the cases. 13% of the cases contained mutations in HLA-A or CIITA , most of which were inactivating, suggesting possible defects in immune surveillance. DDX3X and TP53 mutations were detected in 19% and 10% of the cases, respectively. TP53 mutations were mutually exclusive with mutations in DDX3X and, except for one case, with STAT3 also. MGA mutations, which were present in 12% of the cases, were usually concurrent with STAT3 mutations. The mutational profiles of Chinese and Hispanic cases were similar, and only CD58 mutations were significantly more common in Hispanic patients (p=0.03). Comparison between NKTCL with localized and systemic presentation demonstrated that CCR7 was mutated more frequently in systemic cases (p=0.02). Prognostic analysis identified EP300 mutations as a potential marker for poorer survival (p=0.01). Frequent copy loss on chromosome 6q was observed and PRDM1 , which is present on 6q, was mutated in 10% of the cases. In summary, we identified the profile of mutated genes in a large series of NKTCL. Most of the genes have been previously reported to be mutated in NKTCL, but the frequencies for some of the mutants were quite different. Interestingly, the mutational profiles of NKTCL in Chinese and Hispanic patients were very similar despite the geographic differences. Mutations leading to abnormal activation of the JAK-STAT3 pathway and abnormal chromatin modification were highly prevalent. BCOR , DDX3X and TP53 mutations were also frequent. Variants in CCR7 and EP300 were potential markers for systemic disease and poor prognosis, respectively. Disclosures No relevant conflicts of interest to declare.

Mutations of NFKBIA in Biopsy Specimens from Hodgkin Lymphoma

Mutation of IκBα gene in Hodgkins lymphoma:a prelimimary analysis

The Aberrant of IκBα Expression in Hodgkin's Reed-sternberg

A Study of Mechanism of Modulation of NF-κB Activity of HepG2 Cells by BC047440 Genes

[Preliminary Analysis of Mutations in Exon 5 of IkappaBalpha Gene in Hodgkin Lymphoma].

NFKBIE is a predictive factor of survival and is correlated with immune infiltration and antigen processing and presentation in hepatocellular carcinoma

Intrinsic Functional Defects in B Cells of Patients with NFKB2 Mutations

Clinical and Genetic Characteristics of <i>IKZF1</i> Mutation in Chinese Children With B-Cell Acute Lymphoblastic Leukemia

Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID

Abstract 4974: IL-1 Receptor-Associated Kinase-1 and -4 Expression in Hodgkin Lymphoma

NFkB Pathway and Hodgkin Lymphoma

IκBε deficiency accelerates disease development in chronic lymphocytic leukemia

Analysis of C-Kit Gene Mutations in Nasal NK/T-cell Lymphoma

Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas.

Study on the effect and mechanism of NFKBIA on cervical cancer progress in vitro and in vivo

Expression of CD137 in Tumor Cells of Hodgkin Lymphoma from Northern China and Its Application in Pathological Differential Diagnosis

A heterozygous N-terminal truncation mutation of <i>NFKBIA</i> results in an impaired NF-B dependent inflammatory response

A heterozygous N-terminal truncation mutation of NFKBIA results in an impaired NF-κB dependent inflammatory response

[Study of Mutations in 5'-Noncoding Region of BCL-6 Gene in B-cell Non-Hodgkin's Lymphomas].

Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma

Driver Mutations Affecting Natural Killer/T Cell Lymphoma